27 Aug 2025
Johan Emilsson interviewed in connection with interim report
Sprint Biosciences CEO Johan Emilsson was interviewed by Redeye in connection with the publication of the interim report for the second quarter of 2025. See the interview here:
Sprint Biosciences CEO Johan Emilsson was interviewed by Redeye in connection with the publication of the interim report for the second quarter of 2025. See the interview here: